Cargando…
Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells
Recently, breakthroughs have been made in the use of mesenchymal stem cells (MSCs) to treat various diseases. Several stem cell types have been authorized as drugs by the European Medicines Agency and the U.S. Food and Drug Administration. The Chinese official document “Notification of the managemen...
Autores principales: | He, Fang, Yu, Changyin, Liu, Tao, Jia, Huilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989539/ https://www.ncbi.nlm.nih.gov/pubmed/32038244 http://dx.doi.org/10.3389/fphar.2019.01565 |
Ejemplares similares
-
Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells
por: He, Fang, et al.
Publicado: (2021) -
Relationship Between Ginsenoside Rg3 and Metabolic Syndrome
por: Lee, Hyunji, et al.
Publicado: (2020) -
Protective effects of ginsenosides Rg1 and Rb1 against cognitive impairment induced by simulated microgravity in rats
por: Jiang, Ning, et al.
Publicado: (2023) -
Anti-adipogenic Effects and Mechanisms of Ginsenoside Rg3 in Pre-adipocytes and Obese Mice
por: Zhang, Longyun, et al.
Publicado: (2017) -
Ginsenoside Rg1 Ameliorates Neuroinflammation via Suppression of Connexin43 Ubiquitination to Attenuate Depression
por: Wang, Huiqin, et al.
Publicado: (2021)